These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2862713)

  • 21. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL; Saiman L; Konstan MW; Melnick D
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Stenvang Pedersen S; Pressler T; Pedersen M; Høiby N; Friis-Møller A; Koch C
    Scand J Infect Dis; 1986; 18(2):133-7. PubMed ID: 3518048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Hodson ME; Penketh AR; Batten JC
    Lancet; 1981 Nov; 2(8256):1137-9. PubMed ID: 6118579
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of tobramycin, gentamicin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys.
    Saslaw S; Carlisle HN; Moheimani M
    Antimicrob Agents Chemother; 1972 Sep; 2(3):164-72. PubMed ID: 4208275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of high-dose tobramycin-carbenicillin therapy in pseudomonal infections in cystic fibrosis.
    Fraser GL; Valenti AJ; Grimes GR; Corbin RP
    Drug Intell Clin Pharm; 1985 Oct; 19(10):757-61. PubMed ID: 4053983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftazidime treatment in cystic fibrosis: resistant organisms in sputum and faeces.
    Dalzell AM; Sunderland D; Hart CA; Heaf DP
    Thorax; 1991 Apr; 46(4):239-41. PubMed ID: 1903896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: preliminary communication.
    De Boeck K; Smet M; Eggermont E
    Pediatr Pulmonol; 1989; 7(3):171-3. PubMed ID: 2508049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.
    Gaman W; Cates C; Snelling CF; Lank B; Ronald AR
    Antimicrob Agents Chemother; 1976 Mar; 9(3):474-80. PubMed ID: 816250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftazidime - a significant advance in the treatment of cystic fibrosis.
    David TJ; Phillips BM; Connor PJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():337-40. PubMed ID: 6352639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of pulmonary infections in patients with cystic fibrosis: a comparative study of ticarcillin and gentamicin.
    Parry MF; Neu HC; Merlino M; Gaerlan PF; Ores CN; Denning CR
    J Pediatr; 1977 Jan; 90(1):144-8. PubMed ID: 401521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cephalosporin therapeutics in cystic fibrosis.
    Blumer JL; Stern RC; Yamashita TS; Myers CM; Reed MD
    J Pediatr; 1986 May; 108(5 Pt 2):854-60. PubMed ID: 3517273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    Lumish RM; Norden CW
    J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of Pseudomonas aeruginosa in sputum.
    Burns MW
    Br Med J; 1973 Aug; 3(5876):382-3. PubMed ID: 4199745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.
    Scott RE; Robson HG
    Antimicrob Agents Chemother; 1976 Oct; 10(4):646-51. PubMed ID: 825035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does monotherapy of pulmonary infections in cystic fibrosis lead to early development of resistant strains of Pseudomonas aeruginosa?
    Watkins J; Francis J; Kuzemko JA
    Scand J Gastroenterol Suppl; 1988; 143():81-5. PubMed ID: 3133756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis.
    Vic P; Ategbo S; Turck D; Husson MO; Launay V; Loeuille GA; Sardet A; Deschildre A; Druon D; Arrouet-Lagande C
    Arch Dis Child; 1998 Jun; 78(6):536-9. PubMed ID: 9713009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.